Beta Drugs Ltd (BETA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002857, "name": "Beta Drugs Ltd", "stock_name": "Beta Drugs Ltd", "full_name": "Beta Drugs Ltd", "name_url": "stocks-analysis/beta-drugs", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "2,146.50", "chg": -38.2, "chgp": "-1.75%", "dir": -1, "prev_price": "2,184.70", "mcapval": "2,175.88 Cr", "mcap": "Micro Cap", "scripcode": "", "symbol": "BETA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE351Y01019", "curr_date": "Jul 01, 01:59 PM", "curr_time": "14:17 PM", "last_traded_at": "Jul 01, 01:59 PM IST", "bse_nse_vol": 13758, "exc_status": "Active", "traded_date": "Jul 01, 2026", "traded_date_str": "2026 07 01", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/beta-drugs-1002857-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Beta Drugs Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/beta-drugs-ltd-is-rated-hold-4081493", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BetaDrugsLtd_mojoScore_4081493.png", "date": "2026-07-01 10:10:43", "description": "Beta Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Beta Drugs Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/beta-drugs-ltd-is-rated-hold-by-marketsmojo-4065091", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BetaDrugsLtd_mojoScore_4065091.png", "date": "2026-06-20 10:10:29", "description": "Beta Drugs Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 20 June 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Beta Drugs Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/beta-drugs-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4058233", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BetaDrugsLtd_technicaldot_4058233.png", "date": "2026-06-17 08:06:01", "description": "Beta Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively paint a nuanced picture of the stock’s near-term prospects." }, { "title": "Beta Drugs Ltd Shows Mixed Technical Signals Amid Strong Price Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/beta-drugs-ltd-shows-mixed-technical-signals-amid-strong-price-momentum-4055173", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BetaDrugsLtd_technicaldot_4055173.png", "date": "2026-06-16 08:06:52", "description": "Beta Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in price momentum, supported by a complex mix of technical indicators. Despite a recent upgrade from a mildly bearish to a sideways technical trend, the stock’s price action and momentum oscillators reveal a nuanced picture for investors navigating this evolving landscape." }, { "title": "Beta Drugs Ltd Gains 20.76%: Key Drivers Behind the Surge and Valuation Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/beta-drugs-ltd-gains-2076-key-drivers-behind-the-surge-and-valuation-shift-4050838", "imagepath": "", "date": "2026-06-13 10:08:38", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>8 Jun:</strong> Stock opens at ₹1,430.10, down 2.50%</p>\n <p><strong>9 Jun:</strong> Sharp rebound with 6.49% gain to ₹1,522.90</p>\n <p><strong>10 Jun:</strong> Valuation shifts to very expensive amid strong price gains</p>\n <p><strong>12 Jun:</strong> Surges 19.42% to hit upper circuit at ₹1,760</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹1,466.70</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹1,771.20</div><div class=\"stat..." }, { "title": "Beta Drugs Ltd Locks at Upper Circuit With 19.4% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/beta-drugs-ltd-surges-194-to-hit-upper-circuit-amid-robust-buying-pressure-4049099", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BetaDrugsLtd_stocks_hitting_upper_circuit_4049099.png", "date": "2026-06-12 12:00:14", "description": "At Rs 1,760, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Beta Drugs Ltd locked at its upper circuit of 19.24% on 12 Jun 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Beta Drugs Ltd Valuation Shifts to Very Expensive Amidst Strong Price Gains", "link": "https://www.marketsmojo.com/news/stocks-in-action/beta-drugs-ltd-valuation-shifts-to-very-expensive-amidst-strong-price-gains-4043204", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BetaDrugsLtd_valuationdot_4043204.png", "date": "2026-06-10 08:01:31", "description": "Beta Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating. This change, coupled with a recent 6.49% intraday price surge, invites a closer examination of its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical trends and peer benchmarks." }, { "title": "Beta Drugs Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/beta-drugs-ltd-is-rated-sell-4041027", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BetaDrugsLtd_mojoScore_4041027.png", "date": "2026-06-09 10:10:03", "description": "Beta Drugs Ltd is rated Sell by MarketsMOJO. This rating was last updated on 14 May 2026, reflecting a comprehensive assessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 09 June 2026, providing investors with the latest perspective on the company’s position in the market." }, { "title": "Beta Drugs Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/beta-drugs-ltd-is-rated-sell-by-marketsmojo-4016617", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BetaDrugsLtd_mojoScore_4016617.png", "date": "2026-05-27 10:10:04", "description": "Beta Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." } ], "total": 74, "sid": "1002857", "stock_news_url": "https://www.marketsmojo.com/news/beta-drugs-1002857" }, "announcements": [ { "details": "Beta Drugs Limited has informed the Exchange regarding 'International Plant Approvals'.", "source": "NSE", "caption": "Beta Drugs Limited - Updates", "datetime": "15-Nov-2019" }, { "details": "Beta Drugs Limitedgs Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.", "source": "NSE", "caption": "Beta Drugs Limited - Reply to Clarification- Financial results", "datetime": "14-Nov-2019" }, { "details": "Beta Drugs Limiteded for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.", "source": "NSE", "caption": "Beta Drugs Limited - Clarification - Financial Results", "datetime": "08-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Beta Drugs Ltd has announced <strong>1:20</strong> bonus issue, ex-date: 26 Mar 25", "dt": "2025-03-26", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

8 Jun: Stock opens at ₹1,430.10, down 2.50%

9 Jun: Sharp rebound with 6.49% gain to ₹1,522.90

10 Jun: Valuation shifts to very expensive amid strong price gains

12 Jun: Surges 19.42% to hit upper circuit at ₹1,760

Read full news article

Beta Drugs Ltd Locks at Upper Circuit With 19.4% Gain — Buyers Queue, Sellers Absent

2026-06-12 12:00:14

At Rs 1,760, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Beta Drugs Ltd locked at its upper circuit of 19.24% on 12 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Beta Drugs Ltd Valuation Shifts to Very Expensive Amidst Strong Price Gains

2026-06-10 08:01:31

Beta Drugs Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating. This change, coupled with a recent 6.49% intraday price surge, invites a closer examination of its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical trends and peer benchmarks.

Read full news article

Beta Drugs Ltd is Rated Sell

2026-06-09 10:10:03

Beta Drugs Ltd is rated Sell by MarketsMOJO. This rating was last updated on 14 May 2026, reflecting a comprehensive assessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 09 June 2026, providing investors with the latest perspective on the company’s position in the market.

Read full news article

Beta Drugs Ltd is Rated Sell by MarketsMOJO

2026-05-27 10:10:04

Beta Drugs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article